95 related articles for article (PubMed ID: 21604672)
1. Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents.
Jourdan F; Leese MP; Dohle W; Ferrandis E; Newman SP; Chander S; Purohit A; Potter BV
J Med Chem; 2011 Jul; 54(13):4863-79. PubMed ID: 21604672
[TBL] [Abstract][Full Text] [Related]
2. A-ring-substituted estrogen-3-O-sulfamates: potent multitargeted anticancer agents.
Leese MP; Hejaz HA; Mahon MF; Newman SP; Purohit A; Reed MJ; Potter BV
J Med Chem; 2005 Aug; 48(16):5243-56. PubMed ID: 16078843
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.
Leese MP; Jourdan FL; Gaukroger K; Mahon MF; Newman SP; Foster PA; Stengel C; Regis-Lydi S; Ferrandis E; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV
J Med Chem; 2008 Mar; 51(5):1295-308. PubMed ID: 18260615
[TBL] [Abstract][Full Text] [Related]
4. 2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.
Leese MP; Leblond B; Smith A; Newman SP; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV
J Med Chem; 2006 Dec; 49(26):7683-96. PubMed ID: 17181151
[TBL] [Abstract][Full Text] [Related]
5. 3,17-disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity.
Bubert C; Leese MP; Mahon MF; Ferrandis E; Regis-Lydi S; Kasprzyk PG; Newman SP; Ho YT; Purohit A; Reed MJ; Potter BV
J Med Chem; 2007 Sep; 50(18):4431-43. PubMed ID: 17696419
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate.
Jourdan F; Leese MP; Dohle W; Hamel E; Ferrandis E; Newman SP; Purohit A; Reed MJ; Potter BV
J Med Chem; 2010 Apr; 53(7):2942-51. PubMed ID: 20225862
[TBL] [Abstract][Full Text] [Related]
7. Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.
Jourdan F; Bubert C; Leese MP; Smith A; Ferrandis E; Regis-Lydi S; Newman SP; Purohit A; Reed MJ; Potter BV
Org Biomol Chem; 2008 Nov; 6(22):4108-19. PubMed ID: 18972041
[TBL] [Abstract][Full Text] [Related]
8. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
Ciobanu LC; Poirier D
J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
[TBL] [Abstract][Full Text] [Related]
9. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates.
Newman SP; Leese MP; Purohit A; James DR; Rennie CE; Potter BV; Reed MJ
Int J Cancer; 2004 Apr; 109(4):533-40. PubMed ID: 14991574
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M
J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-substituted 17β-hydroxy/17-methylene estratrienes and their in vitro cytotoxicity in human cancer cell cultures.
Panchapakesan G; Dhayalan V; Dhatchana Moorthy N; Saranya N; Mohanakrishnan AK
Steroids; 2011 Dec; 76(13):1491-504. PubMed ID: 21872616
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
Galal AM; Gul W; Slade D; Ross SA; Feng S; Hollingshead MG; Alley MC; Kaur G; ElSohly MA
Bioorg Med Chem; 2009 Jan; 17(2):741-51. PubMed ID: 19084416
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates.
Raobaikady B; Reed MJ; Leese MP; Potter BV; Purohit A
Int J Cancer; 2005 Oct; 117(1):150-9. PubMed ID: 15880363
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
17. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
Foster PA; Ho YT; Newman SP; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(2):251-60. PubMed ID: 17957467
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
20. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]